Search Results - "Jordan, V C"

The seductive allure is a reductive allure: People prefer scientific explanations that contain logically irrelevant reductive information by Hopkins, Emily J., Weisberg, Deena Skolnick, Taylor, Jordan C.V.

“…Previous work has found that people feel significantly more satisfied with explanations of psychological phenomena when those explanations contain neuroscience…”
Get full text

Deconstructing the Seductive Allure of Neuroscience Explanations by Weisberg, Deena Skolnick, Taylor, Jordan C. V., Hopkins, Emily J.

“…Abstract Previous work showed that people find explanations more satisfying when they contain irrelevant neuroscience information. The current studies…”
Get full text

Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells by Sengupta, S, Obiorah, I, Maximov, PY, Curpan, R, Jordan, VC

“…Background and Purpose Oestrogen receptor alpha (ERα) binds to different ligand which can function as complete/partial oestrogen‐agonist or antagonist. This…”
Get full text

Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death by Obiorah, I, Sengupta, S, Fan, P, Jordan, V C

“…Background: Oestrogen (E 2 ) induces apoptosis in long-term E 2 -deprived MCF7 cells (MCF7:5C). Taxanes have been used extensively in the treatment of early…”
Get full text

Does expertise moderate the seductive allure of reductive explanations? by Hopkins, Emily J., Weisberg, Deena Skolnick, Taylor, Jordan C.V.

“…Non-experts are unduly attracted to explanations of scientific phenomena that contain irrelevant reductive language (e.g., explanations of biological phenomena…”
Get full text

People’s explanatory preferences for scientific phenomena by Weisberg, Deena Skolnick, Hopkins, Emily J., Taylor, Jordan C. V.

“…Previous work has found that people are drawn to explanations of psychological phenomena when these explanations contain neuroscience information, even when…”
Get full text

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial by Cummings, Steven R, Eckert, Stephen, Krueger, Kathryn A, Grady, Deborah, Powles, Trevor J, Cauley, Jane A, Norton, Larry, Nickelsen, Thomas, Bjarnason, Nina H, Morrow, Monica, Lippman, Marc E, Black, Dennis, Glusman, Joan E, Costa, Alberto, Jordan, V. Craig

“…CONTEXT Raloxifene hydrochloride is a selective estrogen receptor modulator that has antiestrogenic effects on breast and endometrial tissue and estrogenic…”
Get full text

Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal by Lewis, J.S., Osipo, C., Meeke, K., Jordan, V.C.

“…Estrogen suppression through the use of an aromatase inhibitor is an effective endocrine treatment option for postmenopausal breast cancer patients with…”
Get full text

MCF-7 : The first hormone-responsive breast cancer cell line by LEVENSON, A. S, JORDAN, V. C

Get full text

Selective estrogen receptor modulation : A personal perspective by JORDAN, V. Craig

Get full text

Selective Estrogen Receptor Modulation and Reduction in Risk of Breast Cancer, Osteoporosis, and Coronary Heart Disease by Jordan, V. Craig, Gapstur, Susan, Morrow, Monica

“…The recognition of selective estrogen receptor modulation in the laboratory has resulted in the development of two selective estrogen receptor modulators…”
Get full text

Solipsistic sentience by Taylor, Jordan C. V.

“…This article examines the nature of affective states across biological taxa. It argues that affect constitutes a primary form of consciousness. Creatures…”
Get full text

Clinical potential of new antiestrogens by Gradishar, W J, Jordan, V C

“…Based on the data and clinical experience derived from tamoxifen usage, the properties of an ideal antiestrogen is described that could have applications as a…”
Get more information

Effects of low dose tamoxifen on normal breast tissue from premenopausal women by de Lima, G.R., Facina, G., Shida, J.Y., Chein, M.B.C., Tanaka, P., Dardes, R.C., Jordan, V.C., Gebrim, L.H.

“…The aim of this study was to determine the effects of low doses of tamoxifen (5 and 10mg/day) for 50 days compared with the standard dose (20 mg/day) on breast…”
Get full text

Antiestrogenic Action of Raloxifene and Tamoxifen: Today and Tomorrow by JORDAN, V. C

“…Tamoxifen must be viewed as a successful example of a first-generation selective estrogen receptor modulator targeted to treat all stages of breast cancer. The…”
Get full text

Effects of the Antiestrogens Tamoxifen, Toremifene, and ICI 182,780 on Endometrial Cancer Growth by O'Regan, Ruth M., Cisneros, Angela, MacGregor, Jennifer L., Muenzner, Henry D., Assikis, Vasilios J., Piette, Michael, Jordan, V. Craig, England, Gale M., Bilimoria, Malcolm M., Chatterton, Robert, Dragan, Yvonne P., Pitot, Henry C.

“…Background: Tamoxifen has been shown to promote the growth of human endometrial tumors implanted in athymic mice, and it has been associated with a twofold to…”
Get full text

Tamoxifen: the Herald of a New Era of Preventive Therapeutics by Jordan, V C

“…An editorial addresses the evolution of the use of tamoxifen from the systemic treatment of breast cancer toward preventive therapeutics…”
Get full text

Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer by Love, Richard R, Mazess, Richard B, Barden, Howard S, Epstein, Sol, Newcomb, Polly A, Jordan, V. Craig, Carbone, Paul P, DeMets, David L

“…TAMOXIFEN is a synthetic antiestrogen that, since its introduction for the treatment of patients with breast cancer in the early 1970s, has come to have a…”
Get full text

A current view of tamoxifen for the treatment and prevention of breast cancer by Jordan, V. Craig

Get full text

Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer by Razandi, M, Pedram, A, Jordan, V C, Fuqua, S, Levin, E R

“…Tamoxifen (TAM) has both cytostatic and cytotoxic properties for breast cancer. TAM engaged mitochondrial estrogen receptor beta (ERβ) as an antagonist in…”
Get full text